ResMed (NYSE:RMD) reported quarterly earnings of $2.95 per share which beat the analyst consensus estimate of $2.89 by 2.08 percent. This is a 15.69 percent increase over earnings of $2.55 per share from the same period last year. The company reported quarterly sales of $1.464 billion which beat the analyst consensus estimate of $1.459 billion by 0.32 percent. This is a 8.61 percent increase over sales of $1.348 billion the same period last year.